Fox Run Management, L.L.C. Spectrum Pharmaceuticals Inc Transaction History

Fox Run Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.5 - $10.35 $44,933 - $132,873	-12,838 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$7.03 - $9.7 $90,251 - $124,528	12,838 New	12,838 $106,000
Q1 2019 Oct 17, 2019	SELL	$9.08 - $11.84 $111,684 - $145,632	-12,300 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$6.39 - $16.99 $78,597 - $208,976	12,300 New	12,300 $108,000
Q3 2018 Oct 05, 2018	SELL	$16.52 - $24.82 $333,984 - $501,785	-20,217 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$14.31 - $21.75 $81,753 - $124,257	5,713 Added 39.39%	20,217 $424,000
Q1 2018 Apr 17, 2018	BUY	$16.09 - $23.07 $233,369 - $334,607	14,504 New	14,504 $233,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.